Influence of Rebamipide on gastritis in patients with gastritis who underwent endoscopic retrograde cholangiopancreatography due to choledocholithiasis: A pilot study

Jeonbuk National University Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新: 2023年6月26日

适应症

试验速览

暂无简介。

•Patients aged 19 and older who have given voluntary consent to the study and signed the Informed Consent Form (ICF)
•-Patients underwent ERCP for the first time after being diagnosed with choledocholithiasis through an imaging examination
•-Patients confirmed to have erosive gastritis, acute superficial gastritis, etc., through EGD prior to ERCP

•-Patients diagnosed with malignant tumors
•-Patients underwent surgeries for the gastrointestinal and biliary system
•-Patients accompanied by a peptic ulcer requiring treatments
•-Patients who need to maintain biliary stent (plastic or metallic)
•-Patients diagnosed with inflammatory bowel disease
•-Patients diagnosed with rheumatology disease
•-Patients who have taken the following medications within the last 2 weeks whose concomitant administration is prohibited (PPI, H2RA, mucoprotective agent, antibiotics, NSAIDs, probiotics, prebiotics, steroids, and immunosuppressants)
•-As a result of the screening test, pregnant women, lactating women, and patients who may become pregnant and do not use appropriate contraceptive methods (e.g., hormone implantation, intrauterine device, oral contraceptives, etc.).

发起方